Ani Pharmaceuticals Inc (ANIP)

Apr 29, 2025

The 4.0% return this week takes ANI Pharmaceuticals' (NASDAQ:ANIP) shareholders three-year gains to 135% - simplywall.st

Apr 29, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 24, 2025

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI - TradingView

Apr 24, 2025

Apr 23, 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - TradingView

Apr 23, 2025

Apr 21, 2025

Truist raises ANI Pharmaceuticals target to $65, maintains hold By Investing.com - Investing.com India

Apr 21, 2025

Apr 21, 2025

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating - marketscreener.com

Apr 21, 2025

Apr 17, 2025

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Apr 17, 2025

Apr 15, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com

Apr 15, 2025

Apr 14, 2025

Ani Pharmaceuticals Sr. VP sells $27,583 in stock By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 13, 2025

StockNews.com Downgrades ANI Pharmaceuticals (NASDAQ:ANIP) to Sell - MarketBeat

Apr 13, 2025

Apr 11, 2025

Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings) - Benzinga

Apr 11, 2025

Apr 11, 2025

ANI Pharmaceuticals (ANIP) Set for Potential Earnings Beat - GuruFocus

Apr 11, 2025

Apr 09, 2025

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET - GlobeNewswire

Apr 09, 2025

Apr 09, 2025

ANI Pharmaceuticals Reveals Q1 2025 Earnings Date: Key Executive Insights Coming May 9 - Stock Titan

Apr 09, 2025

Apr 08, 2025

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE - Yahoo Finance

Apr 08, 2025

Apr 07, 2025

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 07, 2025

Apr 07, 2025

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO - TradingView

Apr 07, 2025

Apr 03, 2025

ANI Pharmaceuticals at RBC Conference: Strategic Growth in Rare Diseases By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 03, 2025

Is The Options Market Predicting A Spike In ANI Pharmaceuticals (ANIP) Stock? - Barchart.com

Apr 03, 2025

Apr 03, 2025

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

ANI Pharmaceuticals To Present At RBC Capital Markets Conference; Webcast At 7:45 AM ET - Nasdaq

Apr 03, 2025

Apr 02, 2025

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree - Yahoo Finance

Apr 02, 2025

Mar 31, 2025

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference - GlobeNewswire

Mar 31, 2025

Mar 28, 2025

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Fly 25% But Investors Aren't Buying For Growth - simplywall.st

Mar 28, 2025

Mar 25, 2025

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio - TradingView

Mar 25, 2025

Mar 24, 2025

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Mar 24, 2025

Mar 24, 2025

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross? - Zacks Investment Research

Mar 24, 2025

Mar 21, 2025

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

Alimera Sciences announces change to SmPC allowing all United Kingdom (Great Britain and Northern Ireland) qualified ophthalmic healthcare professionals experienced in intravitreal injections to administer ILUVIEN - PharmiWeb.com

Mar 20, 2025

Mar 19, 2025

Ultragenyx (RARE) Aligns With FDA on Phase III Neuro Study Plans - MSN

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals Launches Kionex Suspension For Electrolyte Imbalance Management: Key Trend Transforming... - WhaTech

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals launches generic Nitazoxanide Tablets By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea -March 19, 2025 at 09:33 am EDT - MarketScreener

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets - GlobeNewswire

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals launches generic Nitazoxanide Tablets - Investing.com

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals Announces The Launch Of Nitazoxanide Tablets -March 19, 2025 at 06:51 am EDT - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Generic Drug Alert: ANI Pharmaceuticals Takes On $36M Market With New Alinia Alternative - StockTitan

Mar 19, 2025

Mar 19, 2025

ANI Pharmaceuticals settles royalty obligation for $17.25 million By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

ANI Pharmaceuticals Eliminates Royalty Obligation On ILUVIEN And YUTIQ - Nasdaq

Mar 18, 2025

Mar 18, 2025

ANI Pharmaceuticals settles royalty obligation for $17.25 million - Investing.com India

Mar 18, 2025

Mar 18, 2025

ANI Pharma buys Iluvien and Yutiq royalties (ANIP:NASDAQ) - Seeking Alpha

Mar 18, 2025

Mar 18, 2025

ANI Pharma buys royalties linked to Iluvien and Yutiq - MSN

Mar 18, 2025

Mar 18, 2025

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq -March 18, 2025 at 08:20 am EDT - Marketscreener.com

Mar 18, 2025